V. Costa

The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-g (PPARg) and thiazolidinedione- PPARg agonists

D. Foti, E. Chiefari, F. Paonessa, 2008 .

The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists.

A. Fusco, D. Foti, E. Chiefari, 2008, Endocrine-related cancer.

Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer.

A. Fusco, A. Brunetti, D. Foti, 2006, Cancer research.